Autres langues Gland Pharma Limited

Actions

GLAND

INE068V01023

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:48 06/06/2024			Varia. 5j.	Varia. 1 janv.
1 833 ^INR	+0,01 %		-0,91 %	-4,74 %

31/05	Gland Pharma Limited annonce la démission de C.S. Venkatesan en tant que Vice-président senior (R&D) et SMP, à compter du 30 juin 2024 et du 1er juillet 2024 respectivement	CI
24/05	Gland Pharma obtient zéro observation de la part de la FDA américaine pour son usine d'ingrédients pharmaceutiques actifs dans l'Andhra Pradesh, en Inde	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Gland Pharma Limited Announces Resignation of C.S. Venkatesan as Sr. Vice President (R&D) and SMP, Effective June 30, 2024 and July 1, 2024 Respectively	31/05
Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India	24/05
Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit	23/05
Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024	22/05
Gland Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	22/05
Gland Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	22/05
Gland Pharma Gets US FDA's Approval for Generic ALS Drug	07/05
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Edaravone Injection	07/05
Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection	07/05
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Plerixafor Injection	07/05
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	06/05
Gland Pharma Names COO	29/04
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024	29/04
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	29/04
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection	29/04
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals	08/04
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection	08/04
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Eribulin Mesylate Injection 0.5 Mg/ML Single Dose Vial	06/04
Gland Pharma COO, Chief Technical Officer Step Down	25/03
Gland Pharma Limited Announces Change in Management	25/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Gland Pharma Limited

Actions

GLAND

INE068V01023

Autres langues

Filtres